Iterum Therapeutics Files Q1 2025 10-Q
Ticker: ITRM · Form: 10-Q · Filed: May 13, 2025 · CIK: 1659323
| Field | Detail |
|---|---|
| Company | Iterum Therapeutics PLC (ITRM) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Iterum Therapeutics filed its Q1 2025 10-Q. Financials and ops update.
AI Summary
Iterum Therapeutics plc filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Key financial figures and operational details are outlined in the filing, which is a standard quarterly report for public companies.
Why It Matters
This filing provides investors with a detailed look at Iterum Therapeutics' financial health and operational progress during the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Iterum Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the sector.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 20250513 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Iterum Therapeutics plc (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date
- 001-38503 (dollar_amount) — SEC File Number
- 3 DUBLIN LANDINGS (location) — Company Business Address
FAQ
What is the SEC file number for Iterum Therapeutics plc?
The SEC file number for Iterum Therapeutics plc is 001-38503.
What is the fiscal year end for Iterum Therapeutics plc?
The fiscal year end for Iterum Therapeutics plc is December 31 (1231).
When was Iterum Therapeutics plc formerly known as Iterum Therapeutics Ltd?
The company changed its name from Iterum Therapeutics Ltd on November 24, 2015 (20151124).
What is the primary business address of Iterum Therapeutics plc?
The primary business address is 3 DUBLIN LANDINGS, NORTH WALL QUAY, DUBLIN 1, L2, D01 H104.
What period does this 10-Q filing cover?
This 10-Q filing covers the first quarter of 2025, ending on March 31, 2025 (20250331).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Iterum Therapeutics plc (ITRM).